Plasma Cell Dyscrasias
Conditions
Keywords
Multiple myeloma, Monoclonal gammopathy of undetermined significance, Plasmacytoma, Smoldering multiple myeloma
Brief summary
This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research
Interventions
OTHERThis is a non-interventional trial
This is a non-interventional trial
Sponsors
Indiana University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Male or female patients ≥ 18 years of age at the time of informed consent 2. Has been diagnosed with or is suspected to have one of the following: 1. Monoclonal Gammopathy of Undetermined Significance (MGUS) 2. Smoldering Multiple Myeloma 3. Multiple Myeloma 4. Bony or Soft Tissue Plasmacytoma 5. Primary Amyloidosis
Exclusion criteria
\< 18 years of age Have not been diagnosed with one of the following: Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Create a repository | 5 years | The primary objective of this study is to provide a mechanism to store comprehensive clinical, genomic, demographic, social, environmental and quality of life data from subjects with plasma cell dyscrasias |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Data collection | 5 years | To collect data related to clonal evolution, tumor microenvironment, clinical outcomes, adverse events, environmental factors and quality of life that will provide the foundation to create hypotheses for future confirmatory studies. |
Countries
United States
Contacts
Primary ContactAttaya Suvannasankha, MD
Backup ContactNisha George, MD
Outcome results
None listed